Last Updated Last Updated : July 30, 2020 / 02:11 PM IST | Source: Moneycontrol.com

Dr Reddy’s investment case bolstered by improved margins and product launch guidance

Key drag for the Dr Reddy's is India business. Compared to its peers, it has a low revenue share in India and that too is majorly in the acute category

Anubhav Sahu

To view the full content of this article, you have to be a Pro:

  • Already a Moneycontrol Pro subscriber?
  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!